Enterovirus 71

From WikiMD's WELLNESSPEDIA

Enterovirus 71 (EV71) is a virus of the Picornaviridae family, known to cause severe disease in humans. It is one of the most common causes of hand, foot and mouth disease (HFMD), and can also cause severe neurological disease.

Overview[edit]

Electron micrograph of Enterovirus 71

EV71 was first isolated and characterized in California in 1969. It is one of over 100 types of enteroviruses that affect humans, causing a variety of illnesses. EV71 is a non-enveloped virus, meaning it does not have a lipid bilayer surrounding its capsid.

Transmission[edit]

EV71 is primarily transmitted through direct contact with the nasal secretions, saliva, feces, and blister fluid of an infected person. It can also be spread through the aerosol route when an infected person coughs or sneezes.

Symptoms and Complications[edit]

The majority of EV71 infections are mild and self-limiting. Symptoms typically include fever, rash, and small, painful sores in the mouth (herpangina). However, in some cases, EV71 can cause severe neurological disease, including aseptic meningitis, encephalitis, and acute flaccid paralysis. Severe EV71 infections can be life-threatening.

Prevention and Treatment[edit]

There is currently no specific antiviral treatment for EV71. Management of the disease is primarily supportive, focusing on relieving symptoms and preventing complications. Vaccines against EV71 are in development, with some showing promise in early trials.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.